Details
Stereochemistry | RACEMIC |
Molecular Formula | C11H12N2O2S |
Molecular Weight | 236.29 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(N(O)C(N)=O)C1=CC2=C(S1)C=CC=C2
InChI
InChIKey=MWLSOWXNZPKENC-UHFFFAOYSA-N
InChI=1S/C11H12N2O2S/c1-7(13(15)11(12)14)10-6-8-4-2-3-5-9(8)16-10/h2-7,15H,1H3,(H2,12,14)
Molecular Formula | C11H12N2O2S |
Molecular Weight | 236.29 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:53:14 UTC 2023
by
admin
on
Fri Dec 15 15:53:14 UTC 2023
|
Record UNII |
V1L22WVE2S
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NDF-RT |
N0000008683
Created by
admin on Fri Dec 15 15:53:14 UTC 2023 , Edited by admin on Fri Dec 15 15:53:14 UTC 2023
|
||
|
NDF-RT |
N0000175956
Created by
admin on Fri Dec 15 15:53:14 UTC 2023 , Edited by admin on Fri Dec 15 15:53:14 UTC 2023
|
||
|
LIVERTOX |
NBK548397
Created by
admin on Fri Dec 15 15:53:14 UTC 2023 , Edited by admin on Fri Dec 15 15:53:14 UTC 2023
|
||
|
NCI_THESAURUS |
C1322
Created by
admin on Fri Dec 15 15:53:14 UTC 2023 , Edited by admin on Fri Dec 15 15:53:14 UTC 2023
|
||
|
NDF-RT |
N0000175955
Created by
admin on Fri Dec 15 15:53:14 UTC 2023 , Edited by admin on Fri Dec 15 15:53:14 UTC 2023
|
||
|
NDF-RT |
N0000008683
Created by
admin on Fri Dec 15 15:53:14 UTC 2023 , Edited by admin on Fri Dec 15 15:53:14 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
759277
Created by
admin on Fri Dec 15 15:53:14 UTC 2023 , Edited by admin on Fri Dec 15 15:53:14 UTC 2023
|
PRIMARY | |||
|
DB00744
Created by
admin on Fri Dec 15 15:53:14 UTC 2023 , Edited by admin on Fri Dec 15 15:53:14 UTC 2023
|
PRIMARY | |||
|
730712
Created by
admin on Fri Dec 15 15:53:14 UTC 2023 , Edited by admin on Fri Dec 15 15:53:14 UTC 2023
|
PRIMARY | |||
|
CHEMBL93
Created by
admin on Fri Dec 15 15:53:14 UTC 2023 , Edited by admin on Fri Dec 15 15:53:14 UTC 2023
|
PRIMARY | |||
|
100000079065
Created by
admin on Fri Dec 15 15:53:14 UTC 2023 , Edited by admin on Fri Dec 15 15:53:14 UTC 2023
|
PRIMARY | |||
|
10112
Created by
admin on Fri Dec 15 15:53:14 UTC 2023 , Edited by admin on Fri Dec 15 15:53:14 UTC 2023
|
PRIMARY | |||
|
AA-18
Created by
admin on Fri Dec 15 15:53:14 UTC 2023 , Edited by admin on Fri Dec 15 15:53:14 UTC 2023
|
PRIMARY | |||
|
111406-87-2
Created by
admin on Fri Dec 15 15:53:14 UTC 2023 , Edited by admin on Fri Dec 15 15:53:14 UTC 2023
|
PRIMARY | |||
|
6595
Created by
admin on Fri Dec 15 15:53:14 UTC 2023 , Edited by admin on Fri Dec 15 15:53:14 UTC 2023
|
PRIMARY | |||
|
C26667
Created by
admin on Fri Dec 15 15:53:14 UTC 2023 , Edited by admin on Fri Dec 15 15:53:14 UTC 2023
|
PRIMARY | |||
|
V1L22WVE2S
Created by
admin on Fri Dec 15 15:53:14 UTC 2023 , Edited by admin on Fri Dec 15 15:53:14 UTC 2023
|
PRIMARY | |||
|
Zileuton
Created by
admin on Fri Dec 15 15:53:14 UTC 2023 , Edited by admin on Fri Dec 15 15:53:14 UTC 2023
|
PRIMARY | |||
|
C063449
Created by
admin on Fri Dec 15 15:53:14 UTC 2023 , Edited by admin on Fri Dec 15 15:53:14 UTC 2023
|
PRIMARY | |||
|
1724656
Created by
admin on Fri Dec 15 15:53:14 UTC 2023 , Edited by admin on Fri Dec 15 15:53:14 UTC 2023
|
PRIMARY | |||
|
ZILEUTON
Created by
admin on Fri Dec 15 15:53:14 UTC 2023 , Edited by admin on Fri Dec 15 15:53:14 UTC 2023
|
PRIMARY | |||
|
60490
Created by
admin on Fri Dec 15 15:53:14 UTC 2023 , Edited by admin on Fri Dec 15 15:53:14 UTC 2023
|
PRIMARY | |||
|
SUB00157MIG
Created by
admin on Fri Dec 15 15:53:14 UTC 2023 , Edited by admin on Fri Dec 15 15:53:14 UTC 2023
|
PRIMARY | |||
|
DTXSID9023752
Created by
admin on Fri Dec 15 15:53:14 UTC 2023 , Edited by admin on Fri Dec 15 15:53:14 UTC 2023
|
PRIMARY | |||
|
40575
Created by
admin on Fri Dec 15 15:53:14 UTC 2023 , Edited by admin on Fri Dec 15 15:53:14 UTC 2023
|
PRIMARY | RxNorm | ||
|
V1L22WVE2S
Created by
admin on Fri Dec 15 15:53:14 UTC 2023 , Edited by admin on Fri Dec 15 15:53:14 UTC 2023
|
PRIMARY | |||
|
m11593
Created by
admin on Fri Dec 15 15:53:14 UTC 2023 , Edited by admin on Fri Dec 15 15:53:14 UTC 2023
|
PRIMARY | Merck Index | ||
|
5297
Created by
admin on Fri Dec 15 15:53:14 UTC 2023 , Edited by admin on Fri Dec 15 15:53:14 UTC 2023
|
PRIMARY | |||
|
2862
Created by
admin on Fri Dec 15 15:53:14 UTC 2023 , Edited by admin on Fri Dec 15 15:53:14 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
EXCRETED UNCHANGED |
FECAL; URINE
|
||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
ENANTIOMER -> RACEMATE | |||
|
ENANTIOMER -> RACEMATE | |||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
BINDER->LIGAND |
BINDING
|
||
|
TARGET -> INHIBITOR | |||
|
BINDER->LIGAND |
BINDING
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT |
IN-VITRO
|
||
|
METABOLITE -> PARENT |
|
||
|
METABOLITE -> PARENT |
IN-VITRO
|
||
|
METABOLITE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Biological Half-life | PHARMACOKINETIC |
|
|
|||
Route of Elimination | PHARMACOKINETIC |
|
|
|||
Tmax | PHARMACOKINETIC |
|
ORAL ADMINISTRATION |
|
||
Volume of Distribution | PHARMACOKINETIC |
|
|
|||
Tmax | PHARMACOKINETIC |
|
ORAL ADMINISTRATION |
|
||
Route of Elimination | PHARMACOKINETIC |
|